Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald B Brock

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
BJU International|February 9, 2012
Penile Doppler sonographic and clinical characteristics in Peyronie's disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunctionEric Chung, Hanmu Yan, Ling De Young, et al.
Journal of Andrology|August 5, 2004
Oxidative stress and antioxidant therapy: their impact in diabetes-associated erectile dysfunctionLing De Young, Darryl Yu, Ryon M Bateman, et al.
Urology|October 31, 2006
Minimally invasive intracorporeal incision of Peyronie's plaque: initial experiences with a new techniqueAnthony J Bella, Kenneth A Beasley, Ali Obied, et al.
The Journal of Sexual Medicine|January 7, 2012
How to evaluate the efficacy of the phosphodiesterase type 5 inhibitorsEmmanuele A Jannini, Leonard R DeRogatis, Eric Chung, et al.
Sexual Medicine|May 13, 2025
Addressing unmet needs for patients with erectile dysfunction: a narrative review of topical therapiesGerald B Brock, Wayne J G Hellstrom, Annamaria Giraldi, et al.
Journal of Andrology|June 18, 2011
Daily use of sildenafil improves endothelial function in men with type 2 diabetesLing Deyoung, Eric Chung, Jason R Kovac, et al.
The Journal of Urology|November 24, 2012
A comparative study of the efficacy of intralesional verapamil versus normal saline injection in a novel Peyronie disease animal model: assessment of immunohistopathological changes and erectile function outcomeEric Chung, Francisco Garcia, Ling De Young, et al.
European Urology|July 25, 2007
Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indicationsAnthony J Bella, Ling X Deyoung, Mussa Al-Numi, et al.
The Canadian Journal of Urology|November 2, 2006
Non-arteritic anterior ischemic optic neuropathy (NAION) and phosphodiesterase type-5 inhibitorsAnthony J Bella, William O Brant, Tom F Lue, et al.
European Urology|March 18, 2008
Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic ratsLing X De Young, Trustin Domes, Kokbin Lim, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
BJU International|February 9, 2012
Penile Doppler sonographic and clinical characteristics in Peyronie's disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunctionEric Chung, Hanmu Yan, Ling De Young, et al.
Journal of Andrology|August 5, 2004
Oxidative stress and antioxidant therapy: their impact in diabetes-associated erectile dysfunctionLing De Young, Darryl Yu, Ryon M Bateman, et al.
Urology|October 31, 2006
Minimally invasive intracorporeal incision of Peyronie's plaque: initial experiences with a new techniqueAnthony J Bella, Kenneth A Beasley, Ali Obied, et al.
The Journal of Sexual Medicine|January 7, 2012
How to evaluate the efficacy of the phosphodiesterase type 5 inhibitorsEmmanuele A Jannini, Leonard R DeRogatis, Eric Chung, et al.
Sexual Medicine|May 13, 2025
Addressing unmet needs for patients with erectile dysfunction: a narrative review of topical therapiesGerald B Brock, Wayne J G Hellstrom, Annamaria Giraldi, et al.
Journal of Andrology|June 18, 2011
Daily use of sildenafil improves endothelial function in men with type 2 diabetesLing Deyoung, Eric Chung, Jason R Kovac, et al.
The Journal of Urology|November 24, 2012
A comparative study of the efficacy of intralesional verapamil versus normal saline injection in a novel Peyronie disease animal model: assessment of immunohistopathological changes and erectile function outcomeEric Chung, Francisco Garcia, Ling De Young, et al.
European Urology|July 25, 2007
Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indicationsAnthony J Bella, Ling X Deyoung, Mussa Al-Numi, et al.
The Canadian Journal of Urology|November 2, 2006
Non-arteritic anterior ischemic optic neuropathy (NAION) and phosphodiesterase type-5 inhibitorsAnthony J Bella, William O Brant, Tom F Lue, et al.
European Urology|March 18, 2008
Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic ratsLing X De Young, Trustin Domes, Kokbin Lim, et al.
Pageof 9